Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma (Q84628841)
Jump to navigation
Jump to search
scientific article published on 02 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma |
scientific article published on 02 August 2010 |
Statements
Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma (English)
P A Thompson
H M Prince
J F Seymour
D Ritchie
K Stokes
K Burbury
M Wolf
S Peinert